Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of RPh201 in Healthy Subjects and Alzheimer's Disease
NCT01513967Phase 2Completed
- Sponsor
- Regenera Pharma
- Start
- Jan 2012
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RPh201 in Alzheimer's disease (AD), sponsored by Regenera Pharma. Started Jan 2012; status: completed.
02
Drugs
RPh201
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01513967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01513967.